Abstract 5132: Multi-omics analysis uncovers predictive biomarkers for the efficacy and outcomes of immune checkpoint inhibitor in combination with chemotherapy in advanced unresectable biliary tract cancers
Jieer Ying(Chinese Academy of Medical Sciences & Peking Union Medical College), Haimeng Tang(Unknown), Wei Zhuo(Women's Hospital, School of Medicine, Zhejiang University), Jianying Jin(Wenzhou Medical University), Qiuxiang Ou(Genesee Community College), Junrong Yan, Qinhong Zheng(Quzhou City People's Hospital), Yuan Li(Fudan University), Qi Xu(China Jiliang University), Xiaoying Wu(Johns Hopkins University), Hanlin Chen, Yanru Xie(Lishui Central Hospital), Jiaojiao Ni(Zhejiang Cancer Hospital), Chaoqun Li(Wenzhou Medical University)
Cited by 0
Related Papers
Hepatogastroenterology
|Hepatogastroenterology|2012|1.3k
Longitudinal pattern of regional brain volume change differentiates normal aging from MCI
|Neurology|2009|536
Donafenib Versus Sorafenib in First-Line Treatment of Unresectable or Metastatic Hepatocellular Carcinoma: A Randomized, Open-Label, Parallel-Controlled Phase II-III Trial
|Journal of Clinical Oncology|2021|417